Healthlinx Limited Company Summary |
|
|
COMPANY DATA |
 |
Headquarters |
c/- Grant Thornton , Level 17 , 383 Kent Street |
 |
| |
|
SYDNEY NSW 2000 |
|
|
Telephone |
(03) 9639 6349 |
|
|
Fax |
(03) 9639 7855 |
|
|
Principal Sector |
Health & Pharm General |
|
|
Principal Industry |
None |
|
|
Homepage |
www.healthlinx.com.au |
|
| |
Key Developments: Healthlinx Limited
 |
Asian Activities Report for September 9, 2011: HealthLinx Limited (ASX:HTX) to Commence Ovarian Cancer Diagnostic Study in China
SEP 9, 2011 12:00 - Article Views: 1,381
Asian Activities Report for September 9, 2011 includes: HealthLinx Limited (ASX:HTX) is to begin a 350 patient academic study as the first step to launch the OvPlex(TM) ovarian cancer diagnostic in China; Amex Resources Limited (ASX:AXZ) today provided an update on the Company's recent advancements on the MBa Delta Ironsands Project in Fiji; Orocobre Limited (ASX:ORE) has received approval to drill exploratory wells on its Cauchari Project in Argentina; Coalbank Limited (ASX:CBQ) has engaged an independent technical expert to review its metals projects portfolio. |
|
 |
Australian Market Report of September 2, 2010: Tanami Gold (ASX:TAM) High Grade Results at Central Tanami Project
SEP 2, 2010 13:30 - Article Views: 3,239
Australian Market Report of September 2, 2010 includes; Empire Resources (ASX:ERL) enters into an option agreement with La Mancha Resources, Tanami Gold NL (ASX:TAM) reported further high grade results from its Central Tanami Project, the signing of a Native Title Mining Agreement for development of IronClad Mining's (ASX:IFE) Wilcherry Hill iron ore project and HealthLinx Limited (ASX:HTX) has finalised research agreements to begin the 220 patient study required for South Korea Food and Drug Administration (KFDA). |
|
12,301 COMPANY PROFILE VIEWS |
|
This Page Viewed: (Last 7 Days: 10) (Last 30 Days: 48) (Since Published: 1550)
|
|
|
|
ASX S&P200
ASX:HTX
